The benefits of bispecific antibodies for treating multiple myeloma Published 2020-10-06 Download video MP4 360p Recommendations 02:36 The importance of treating multiple myeloma patients during the COVID-19 pandemic 00:20 What is myeloma? 03:44 Association between elevated WBC counts and thrombotic events in polycythemia vera 1:21:29 Sauna Benefits Deep Dive and Optimal Use with Dr. Rhonda Patrick & MedCram 01:52 How do we know that bacteria were around billions of years ago? 54:01 Aspirin and cancer: the emerging evidence 09:15 Why Am I Always Tired? Avoid These 6 Energy Vampires | Exhausted 14:46 Excess Deaths at Night - Obstructive Sleep Apnea Explained Clearly 01:44 The role of belantamab mafodotin in multiple myeloma: the DREAMM-7 and DREAMM-8 trials 05:57 Additional Advances in Multiple Myeloma Research and Clinical Trials With Rahul Banerjee, MD, FACP 45:50 Treating Persistent/Chronic ITP Current Care, Future Potential 7:35:04 REdI Annual Conference 2024: CDER (Drugs) Innovation in Medical Product Development (Day 1 of 2) 02:03 The impact of JAK2 allele burden on the efficacy of JAK inhibitors in myelofibrosis 02:49 What are the side effects of immunotherapy? 5:41:06 REdI Annual Conference 2024: CDRH (Devices) Innovation in Medical Product Development (Day 1 of 2) 16:16 Brain Tumor Awareness Month: Providing Hope Through Research 01:41 Mitigating toxicities related to epcoritamab in follicular lymphoma: insights from EPCORE-1 08:32 Peter Dauvergne (University of British Columbia, Vancouver, Canada) Similar videos 03:25 What should myeloma patients know about bispecific antibodies? 12:01 What are Bispecific Antibodies? How they are Revolutionizing Multiple Myeloma Treatment! 06:15 Patrick Laroche, ASCO20: Bispecific Antibodies in the Treatment of Multiple Myeloma 09:57 Teclistamab, a BCMA × Cd3 Bispecific Antibody, in Pts with RRMM: Updated Phase 1 Results 06:09 Bispecific Antibodies | High Impact Topic (HIT) 04:35 Bispecific antibodies vs CAR T-cells for R/R multiple myeloma 04:45 Bispecifics Part 2: Monoclonal and Bispecific Antibodies 04:01 What are the differences between CAR T-cell therapy and bispecific antibodies? 00:55 What are Bispecific Antibodies? 36:17 Update on Multiple Myeloma Treatment: Kenneth C. Anderson, MD 55:48 Hitting the BCMA Target in Multiple Myeloma 57:20 Know Your Myeloma Immunotherapy: Bispecific Antibodies with Dr. Cesar Rodriguez 42:30 Multiple Myeloma Treatments: How Close Are We To a CURE? | The Patient Story 01:20 A comparison of bispecific antibodies emerging in multiple myeloma 01:52 How Is Bispecific Antibody Therapy Changing Myeloma Care? 07:05 Developments in the use of bispecific antibodies in myeloma and challenges in this space 04:15 Bispecific antibodies in multiple myeloma: teclistamab, talquetamab, and cevostamab 18:32 Updates in Multiple Myeloma from ASCO 2020 33:21 Multiple Myeloma - 2023 Best of Hematology Conference More results